BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38293830)

  • 1. Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport Times.
    van Diepen S; Zheng Y; Senaratne JM; Tyrrell BD; Das D; Thiele H; Henry TD; Bainey KR; Welsh RC
    Circ Cardiovasc Interv; 2024 Feb; 17(2):e013415. PubMed ID: 38293830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry.
    Bainey KR; Armstrong PW; Zheng Y; Brass N; Tyrrell BD; Leung R; Westerhout CM; Welsh RC
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e008059. PubMed ID: 31607152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
    Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.
    Shavadia J; Welsh R; Gershlick A; Zheng Y; Huber K; Halvorsen S; Steg PG; Van de Werf F; Armstrong PW
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 28525886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.
    Kolte D; Sardar P; Khera S; Zeymer U; Thiele H; Hochadel M; Radovanovic D; Erne P; Hambraeus K; James S; Claessen BE; Henriques JPS; Mylotte D; Garot P; Aronow WS; Owan T; Jain D; Panza JA; Frishman WH; Fonarow GC; Bhatt DL; Aronow HD; Abbott JD
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?
    Shavadia J; Zheng Y; Dianati Maleki N; Huber K; Halvorsen S; Goldstein P; Gershlick AH; Wilcox R; Van de Werf F; Armstrong PW
    J Am Heart Assoc; 2015 Aug; 4(8):e002049. PubMed ID: 26304934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of a Pharmacoinvasive Strategy in ST-Segment Elevation Myocardial Infarction: A Patient Population Study Comparing a Pharmacoinvasive Strategy With a Primary Percutaneous Coronary Intervention Strategy Within a Regional System.
    Rashid MK; Guron N; Bernick J; Wells GA; Blondeau M; Chong AY; Dick A; Froeschl MPV; Glover CA; Hibbert B; Labinaz M; Marquis JF; Osborne C; So DY; Le May MR
    JACC Cardiovasc Interv; 2016 Oct; 9(19):2014-2020. PubMed ID: 27712737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes of Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: A Study from Mexico City.
    Arias-Mendoza A; Gopar-Nieto R; Juarez-Tolen J; Ordóñez-Olvera JC; Gonzalez-Pacheco H; Briseño-De la Cruz JL; Sierra-Lara Martinez D; Mendoza-García S; Altamirano-Castillo A; Montañez-Orozco A; Arzate-Ramirez A; Baeza-Herrera LA; Ortega-Hernandez JA; Miranda-Cerda G; Cruz-Martinez JE; Baranda-Tovar FM; Zabal-Cerdeira C; Araiza-Garaygordobil D
    Am J Cardiol; 2024 May; 218():7-15. PubMed ID: 38402926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country.
    Chacón-Diaz M; Custodio-Sánchez P; Rojas De la Cuba P; Yábar-Galindo G; Rodríguez-Olivares R; Miranda-Noé D; López-Rojas LM; Hernández-Vásquez A
    BMC Cardiovasc Disord; 2022 Jun; 22(1):296. PubMed ID: 35768779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Reperfusion Strategies for ST-Segment-Elevation Myocardial Infarction: A Multivariate Network Meta-analysis.
    Fazel R; Joseph TI; Sankardas MA; Pinto DS; Yeh RW; Kumbhani DJ; Nallamothu BK
    J Am Heart Assoc; 2020 Jun; 9(12):e015186. PubMed ID: 32500800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the OPTIMAL-REPERFUSION trial: A prospective randomized multi-center clinical trial comparing different fibrinolysis-transfer percutaneous coronary intervention strategies in acute ST-segment elevation myocardial infarction.
    Chen Z; Wang D; Ma M; Li C; Wan Z; Zhang L; Zhu Y; Wang M; Wang H; He S; Peng Y; Wei J; Huang B; He Y;
    Clin Cardiol; 2021 Apr; 44(4):455-462. PubMed ID: 33634478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.
    Van de Werf F; Ristić AD; Averkov OV; Arias-Mendoza A; Lambert Y; Kerr Saraiva JF; Sepulveda P; Rosell-Ortiz F; French JK; Musić LB; Vandenberghe K; Bogaerts K; Westerhout CM; Pagès A; Danays T; Bainey KR; Sinnaeve P; Goldstein P; Welsh RC; Armstrong PW;
    Circulation; 2023 Aug; 148(9):753-764. PubMed ID: 37439219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network).
    Siontis KC; Barsness GW; Lennon RJ; Holmen JL; Wright RS; Bell MR; Gersh BJ
    Am J Cardiol; 2016 Jun; 117(12):1904-10. PubMed ID: 27131614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observational study comparing pharmacoinvasive strategy with primary percutaneous coronary intervention in patients presenting with ST elevation myocardial infarction to a tertiary care centre in India.
    Alex AG; Lahiri A; ; Geevar T; George OK
    J Postgrad Med; 2018; 64(2):80-85. PubMed ID: 29067927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis Comparing Primary Percutaneous Coronary Intervention Versus Pharmacoinvasive Therapy in Transfer Patients with ST-Elevation Myocardial Infarction.
    Siddiqi TJ; Usman MS; Khan MS; Sreenivasan J; Kassas I; Riaz H; Raza S; Deo SV; Sharif H; Kalra A; Yadav N
    Am J Cardiol; 2018 Aug; 122(4):542-547. PubMed ID: 30205885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study).
    Welsh RC; Van de Werf F; Westerhout CM; Goldstein P; Gershlick AH; Wilcox RG; Danays T; Bluhmki E; Lopes RD; Steg PG; Armstrong PW
    Am J Cardiol; 2014 Sep; 114(6):811-9. PubMed ID: 25108302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery-Only Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Kim HK; Hwang D; Lee SH; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Chae SC; Cho MC; Kim CJ; Kim JH; Kim HS; Gwon HC; Jeong MH; Hahn JY;
    J Am Heart Assoc; 2019 Dec; 8(24):e013870. PubMed ID: 31818215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pharmacoinvasive strategy versus percutaneous coronary intervention in patients with acute myocardial infarction with ST segment elevation at the National Institute of Cardiology (PHASE-MX).
    Baeza-Herrera LA; Araiza-Garaygordobil D; Gopar-Nieto R; Raymundo-Martínez GI; Loáisiga-Sáenz A; Villalobos-Flores A; Martínez-Ramos M; Torres-Araujo LV; Pohls-Vázquez R; Luna-Herbert A; Alonso-Vázquez A; Delgado-Cruz IV; Cabello-López A; Martínez-Amezcua P; Arias-Mendoza MA
    Arch Cardiol Mex; 2020; 90(2):158-162. PubMed ID: 32459215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry.
    Zubaid M; Khraishah H; Alahmad B; Rashed W; Ridha M; Alenezi F; Aljarralah M; Al-Marri K; Almutairi M; Althalji K; Alfaddagh A
    Ann Glob Health; 2020 Feb; 86(1):13. PubMed ID: 32064231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.